Search - tctmd.com

Displaying 181 - 200 of 238

Sort: Relevancy | Date

Presentation Fellows 2013

Renal Denervation for Resistant Hypertension

Presenter: Ajay Kirtane

April 17, 2013

News Industry News

New Data Reinforce Significant Blood Pressure Reduction Sustained to Two Years Using the Symplicity™ Renal Denervation System

March 09, 2013

News Industry News

St. Jude Medical Initiates Landmark Study of Renal Denervation for Reduction of Heart Attack, Stroke and Death

February 14, 2013

Presentation TCT 2013

Renal Sympathetic Denervation - Inducing An Instantaneous And Persisting 24h Ambulatory Blood Pressure Drop In Patients With Resistant Hypertension – Results From The...

Presenter: Alexander Plehn, Sebastian Dietz, Konstantin Heinroth, Henning Lemm, Maria Leuthold, Silke Markau, Uwe Raaz, Therese Schubert, Alexander Vogt, Karl Werdan

January 31, 2013

Presentation TCT 2013

A Pilot Study on Renal Sympathetic Denervation for Resistant Hypertension in the West of Ireland

Presenter: IMTIAZ KALYAR, James Gleeson, Sajjad Matiullah, Faisal Sharif

January 31, 2013

News Daily News

Renal Denervation Appears Safe for Patients with Kidney Dysfunction

January 09, 2013

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2012

Jason Kahn

January 02, 2013

News Daily News

Renal Denervation Shows Sustained BP Improvements at 1 Year

Jason Kahn

December 26, 2012

News Daily News

La Denervación Renal Confirma Mejoras Sostenidas de la Presión Arterial al cabo de 1 Año

Jason Kahn

December 26, 2012

Presentation

Renal Sympathetic Denervation for Treatment of Drug-resistant Hypertension

Presenter: Murray Esler

December 19, 2012

News Industry News

One-Year Results from the Symplicity HTN-2 Randomized Controlled Trial Published in Circulation

December 16, 2012

News Daily News

Un Modelo Confirma la Rentabilidad de la Denervación Renal en Varones y Mujeres

L.A. McKeown

December 02, 2012

News Daily News

Model Shows Cost-Effectiveness of Renal Denervation in Men, Women

L.A. McKeown

December 02, 2012

Presentation

Potential Lifetime Cost-effectiveness ofCatheter-Based Renal Sympathetic Denervation in Patients with Resistant Hypertension

Presenter: Marc Dorenkamp

November 29, 2012

News Conference News AHA 2012

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Jason Kahn

November 11, 2012

News Industry News

Significant Blood Pressure Reduction from St. Jude Medical's EnligHTN Renal Denervation Technology is Safe, Effective and Sustained at Six Months

November 04, 2012

News Conference News AHA 2012

Early Study Shows Positive Clinical Results with Novel Renal Denervation Device

Jason Kahn

November 04, 2012

Presentation TCT 2012

A 42-Year-Old Female with True Severe Resistant Hypertension

Presenter: Konstantinos Tsioufis

October 25, 2012

Presentation TCT 2012

Resistant Hypertension: Prevalence and Global Impact

Presenter: Stefan Bertog

October 24, 2012

Presentation TCT 2012

TCT-14. Effects of Renal Sympathetic Denervation on Heart Rate and Atrioventricular Conduction in Patients with Resistant Hypertension

Presenter: Christian Ukena

October 23, 2012

Advertisement

Renal Denervation for Resistant Hypertension

New Data Reinforce Significant Blood Pressure Reduction Sustained to Two Years Using the Symplicity™ Renal Denervation System

St. Jude Medical Initiates Landmark Study of Renal Denervation for Reduction of Heart Attack, Stroke and Death

Renal Sympathetic Denervation - Inducing An Instantaneous And Persisting 24h Ambulatory Blood Pressure Drop In Patients With Resistant Hypertension – Results From The...

A Pilot Study on Renal Sympathetic Denervation for Resistant Hypertension in the West of Ireland

Renal Denervation Appears Safe for Patients with Kidney Dysfunction

TCTMD’s Top 10 Most Popular News Stories for 2012

Renal Denervation Shows Sustained BP Improvements at 1 Year

La Denervación Renal Confirma Mejoras Sostenidas de la Presión Arterial al cabo de 1 Año

Renal Sympathetic Denervation for Treatment of Drug-resistant Hypertension

One-Year Results from the Symplicity HTN-2 Randomized Controlled Trial Published in Circulation

Un Modelo Confirma la Rentabilidad de la Denervación Renal en Varones y Mujeres

Model Shows Cost-Effectiveness of Renal Denervation in Men, Women

Potential Lifetime Cost-effectiveness ofCatheter-Based Renal Sympathetic Denervation in Patients with Resistant Hypertension

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Significant Blood Pressure Reduction from St. Jude Medical's EnligHTN Renal Denervation Technology is Safe, Effective and Sustained at Six Months

Early Study Shows Positive Clinical Results with Novel Renal Denervation Device

A 42-Year-Old Female with True Severe Resistant Hypertension

Resistant Hypertension: Prevalence and Global Impact

TCT-14. Effects of Renal Sympathetic Denervation on Heart Rate and Atrioventricular Conduction in Patients with Resistant Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content